Sangamo Therapeutics, Inc.
Controlled Transgene Expression in Regulatory T Cells

Abstract:

The present disclosure provides mammalian cells such as regulatory T cells containing a transgene in the FOXP3 genomic locus. Also provided are methods of generating the cells and methods of using the cells to treat patients in need of immunosuppression.